MedTrace Logo

Corticosteroids for Children With Febrile Urinary Tract Infections

NCT01391793 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 546

Last updated 2019-07-02

Study results available
· View outcomes & findings →

Summary

In this study the investigators will determine whether corticosteroids given at the time of urinary tract infection help prevent permanent damage to the kidneys.

Conditions

Interventions

DRUG

Placebo

Twice daily for 3 days

DRUG

Dexamethasone

0.15 mg/kg/dose twice daily for 3 days

Sponsors & Collaborators

  • National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

    collaborator NIH

  • Nader Shaikh

    lead OTHER

Principal Investigators

  • Nader Shaikh, MD · University of Pittsburgh

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
2 Months
Max Age
6 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-09-30
Primary Completion
2018-03-30
Completion
2018-03-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01391793 on ClinicalTrials.gov